相关实验视频
Updated: Jul 5, 2025

08:03
In Vivo Mouse Model of Spinal Implant Infection
Published on: June 23, 2020
2.4K
奥里塔万辛作为对格兰氏阳性血流感染的顺序治疗
Williams Monier Texidor1,2, Matthew A Miller3,4,5, Kyle C Molina1,2,6
1Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Science, Aurora, CO, USA.
BMC infectious diseases
|January 24, 2024
概括
在一项现实研究中,奥利塔万有效治疗了格拉姆阳性血流感染 (BSI),显示了低失败率和通过更早的患者出院显著的成本节省.
科学领域:
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
- 卫生经济学 卫生经济学
背景情况:
- 有限的数据存在于奥里塔万对于严重的格拉姆阳性细菌感染.
- 奥里塔万辛是一种被批准用于治疗皮肤感染的脂糖.
研究的目的:
- 评估奥里塔万对于包括感染性内心炎 (IE) 在内的格拉姆阳性血流感染 (BSI) 的有效性和安全性.
- 评估奥里塔万辛作为BSI的整合疗法.
主要方法:
- 成年患者接受奥里塔万辛治疗格拉姆阳性BSI的回顾性队列研究.
- 主要结局:90天复合性失败 (临床/微生物).
- 二次结果:急性损伤 (AKI),输液相关反应 (IRR),避免成本.
主要成果:
- 包括72名患者;常见的病原体是金黄色葡萄球菌 (68%) 和链球菌 spp. (26%). 这一数字是26%.
- 在90天后14%的复合失败率;4%经历了AKI,3%有IRR.
- 在94%的患者中,奥里塔万辛促进了更早的出院,节省了300多万美元的机构成本.
结论:
- 奥里塔万辛显示出潜在的作为有效的顺序疗法,用于阳性BSI.
- 提前释放和避免成本是奥里塔万使用的关键好处.
更多相关视频
相关概念视频
Pulmonary Tuberculosis V
180
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Antibiotic Selection
53.6K
Overview
53.6K
Pneumonia IV: Management
329
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
329
Dosage Regimen: Fixed Dose
1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
Tonsillitis II: Management
111
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
111

